In this presentation Ishita Moghe and Kim Solez highlight the stagnation kidney medicine has faced in recent years with little innovative practice in biopsy analysis and classification. They explain how application of new technologies involving single-cell RNA sequencing (scRNA-seq), digital pathology, and artificial intelligence (AI) will provide the field with the breakthrough it needs to reinterpret kidney lesions and reconfigure disease classifications.

Get the presentation in seconds. Fill in the form opposite.